Sg Americas Securities, LLC Aptinyx Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$3.05 - $4.99 $41,351 - $67,654	-13,558 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.99 - $4.4 $26,980 - $59,655	13,558 New	13,558 $57,000
Q1 2020 Apr 30, 2020	SELL	$1.81 - $5.03 $23,593 - $65,566	-13,035 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$2.84 - $4.25 $2,115 - $3,166	-745 Reduced 5.41%	13,035 $45,000
Q3 2019 Nov 04, 2019	SELL	$3.0 - $4.08 $2,670 - $3,631	-890 Reduced 6.07%	13,780 $48,000
Q2 2019 Jul 29, 2019	BUY	$2.95 - $4.38 $43,276 - $64,254	14,670 New	14,670 $49,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.